DISCOUNT-OPTIONSSCHEIN - AMGEN | Market Closed - BOERSE MUENCHEN 03:46:10 2024-07-16 pm EDT | ||
| 0.097 EUR | +1.04% |
|
| Current month | +23.08% | ||
| 1 month | -20.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-16 | 0.097 | +1.04% |
| 24-07-15 | 0.096 | -3.03% |
| 24-07-12 | 0.099 | +3.13% |
| 24-07-11 | 0.096 | +54.84% |
| 24-07-10 | 0.062 | -11.43% |
Real-time BOERSE MUENCHEN
Last update July 16, 2024 at 03:46 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HC7V8Q |
| ISIN | DE000HC7V8Q2 |
| Date issued | 2023-07-04 |
| Strike | 200 $ |
| Maturity | 2024-12-18 (155 Days) |
| Parity | 10 : 1 |
| Emission price | 0.67 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.68 € |
|---|---|
| Lowest since issue | 0.026 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
330.2
USD
Average target price
317.4
USD
Spread / Average Target
-3.86%
- Stock Market
- Certificates
- Certificat
